跳至主要内容
临床试验/IRCT20181128041780N1
IRCT20181128041780N1已完成2 期

Comparison of the effectiveness of SLN containing finasteride and finasteride tablets in androgenic alopecia

Mashhad University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 45 years(—)
性别
Male

入选标准

  • Men with Androgenic Alopecia Based on Hamilton's Criteria. Stage 2-4
  • Completing the consent form

排除标准

  • No endocrine disease (diabetes), thyroid disorders, systemic diseases including lupus, other cases, including arthritis and cicatrisil (associated with scar), history of skin or systemic malignancy, psychiatric disorders, skin disorders Head skulls other than those with AGASerious Cardiovascular Diseases, Kidney Disease, Liver Disease
  • No use of zinc and iron supplements, malnutrition, iron deficiency anemia
  • Non-use of medications leads to hair loss, including anti-hypertensive and anti-inflammatory drugs, NSAIDs
  • No history of alcohol consumption or substance abuse
  • No history of finasteride in the last 6 months and minoxidil in the past month
  • No history of drug hypersensitivity, breast disorders, surgical history for the treatment of hair loss

研究者

相似试验